Endothelial-to-mesenchyma transition and atherosclerosis
Endothelial-to-mesenchyma transition and atherosclerosis
批准号:
9219801
负责人:
Martin A Schwartz
金额:
$82.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-01-12 至 2020-12-31
关键词:
Apolipoprotein EArterial DisorderArterial Fatty StreakAtherosclerosisBlood VesselsCellsChemicalsChronicClinicalCoronaryCoronary arteryDataDepositionDevelopmentDiseaseDisease ProgressionEventExtracellular MatrixFGFR1 geneFeedbackFibroblast Growth FactorFibroblastsFibronectinsGene ExpressionGeneticGenetically Engineered MouseGrowthHomeostasisHumanInflammationInflammation MediatorsInflammatoryInterferon-alphaInterleukin-1 betaLaboratoriesLinkMaintenanceMediatingMesenchymalMesenchymeMicroRNAsMolecularMolecular BiologyMolecular TargetMusMyocardial InfarctionNatural HistoryOrganPathway interactionsPatientsPeripheral Vascular DiseasesPermeabilityPhenotypePlayProcessProgressive DiseaseReportingRoleSeveritiesSignal TransductionSmall Interfering RNASmooth Muscle MyocytesSpecimenStimulusStrokeTNF geneTechniquesTestingTherapeuticTransforming Growth Factor betaTransplantationbasecell typedisease natural historydriving forcegenetic approachmouse modelnanoparticleneointima formationnovelnovel therapeutic interventionnovel therapeuticspre-clinicalshear stress
中文摘要
项目摘要
血管稳态在维持正常血管和器官功能中起着重要作用
功能我们和其他实验室最近的研究表明,
内皮成纤维细胞生长因子(FGF)信号输入对于维持
血管完整性、渗透性和细胞命运。损失的一个特别重要的后果是
FGF输入的最重要的原因是内皮细胞向间充质细胞转化(EndMT)的发展,
代表从内皮细胞到间充质样细胞(平滑肌细胞(SMC),
成纤维细胞)表型。由慢性炎症和其他尚不清楚的刺激引起,
EndMT导致新生内膜的形成,其由不同细胞类型的组合组成,
平滑肌细胞、成纤维细胞和各种炎症细胞以及细胞外基质的重塑
矩阵(ECM)。
我们已经观察到广泛的EndMT在动脉粥样硬化患者的冠状动脉,
小鼠动脉粥样硬化这些数据表明,EndMT可能对
在与慢性炎症,如动脉粥样硬化,
和移植动脉病如果是正确的,这一假设将从根本上打开一个可能性,
改变这些疾病的自然史,具有相当大的临床影响。
为此,我们的目标是测试EndMT的抑制是否会抑制起始,
动脉粥样硬化病变的进展和消退,并解开信号和基因
连接EndMT、ECM重塑和炎症的表达途径,
这些影响。
英文摘要
Project Summary
Vascular homeostasis plays an important role in maintenance of normal vessel and organ
function. Recent studies from our and other laboratories have established that continuous
endothelial fibroblast growth factor (FGF) signaling input is critical for the maintenance of
vascular integrity, permeability and cell fate. One particularly important consequence of the loss
of FGF input is the development of endothelial-to-mesenchymal transition (EndMT) that
represents a fate transition from endothelial to a mesenchymal-like (smooth muscle cell (SMC),
fibroblast) phenotype. Induced by chronic inflammation and other poorly understood stimuli,
EndMT leads to formation of neointima that consists of a combination of different cell types,
SMCs, fibroblasts and various inflammatory cells as well as remodeling of the extracellular
matrix (ECM).
We have observed extensive EndMT in atherosclerotic coronary arteries in patients and in
mouse atherosclerosis. These data suggest that EndMT may make a major contribution to
disease progression in illnesses associated with chronic inflammation, such as atherosclerosis,
and transplant arteriopathy. If correct, this hypothesis would open a possibility to fundamentally
change the natural history of these illnesses with considerable clinical impact.
To this end, we aim to test whether suppression of EndMT will inhibit will inhibit initiation,
progression and regression of atherosclerotic lesions, and to unravel the signaling and gene
expression pathways that connect EndMT, ECM remodeling and inflammation that mediate
these effects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Endothelial Mechanotransduction in Thoracic Aneurysm Formation and Progression
-
批准号:10378126
-
项目类别:
-
资助金额:$44.29万
-
财政年份:2018
-
负责人:Martin A Schwartz
-
依托单位:
Endothelial-to-mesenchymal transition and atherosclerosis
-
批准号:10551998
-
项目类别:
-
资助金额:$83.56万
-
财政年份:2017
-
负责人:Martin A Schwartz
-
依托单位:
Endothelial-to-mesenchymal transition and atherosclerosis
-
批准号:10330539
-
项目类别:
-
资助金额:$83.56万
-
财政年份:2017
-
负责人:Martin A Schwartz
-
依托单位:
Endothelial-to-mesenchymal transition and atherosclerosis
-
批准号:9973898
-
项目类别:
-
资助金额:$83.56万
-
财政年份:2017
-
负责人:Martin A Schwartz
-
依托单位:
2012 Signaling by Adhesion Receptor Gordon Research Conference and Frontiers in A
-
批准号:8318467
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2012
-
负责人:Martin A Schwartz
-
依托单位:
ECM and shear stress
-
批准号:10192388
-
项目类别:
-
资助金额:$52.05万
-
财政年份:2012
-
负责人:Martin A Schwartz
-
依托单位:
ECM and shear stress
-
批准号:10433820
-
项目类别:
-
资助金额:$52.05万
-
财政年份:2012
-
负责人:Martin A Schwartz
-
依托单位:
2011 Vascular Cell Biology Gordon Research Conference
-
批准号:8062789
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2011
-
负责人:Martin A Schwartz
-
依托单位:
Project 2: Integrin Signaling and Physical Forces
-
批准号:8234227
-
项目类别:
-
资助金额:$27.46万
-
财政年份:2011
-
负责人:Martin A Schwartz
-
依托单位:
Understanding the RhoGDI2 metastasis suppressor gene
-
批准号:8505399
-
项目类别:
-
资助金额:$33.12万
-
财政年份:2010
-
负责人:Martin A Schwartz
-
依托单位:
2010 Signalling by Adhesion Receptors Gordon Research Conference
-
批准号:7900217
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2010
-
负责人:Martin A Schwartz
-
依托单位:
Understanding the RhoGDI2 metastasis suppressor gene
-
批准号:8319571
-
项目类别:
-
资助金额:$36.85万
-
财政年份:2010
-
负责人:Martin A Schwartz
-
依托单位:
Understanding the RhoGDI2 metastasis suppressor gene
-
批准号:8697021
-
项目类别:
-
资助金额:$33.21万
-
财政年份:2010
-
负责人:Martin A Schwartz
-
依托单位:
Understanding the RhoGDI2 metastasis suppressor gene
-
批准号:8147839
-
项目类别:
-
资助金额:$37.23万
-
财政年份:2010
-
负责人:Martin A Schwartz
-
依托单位:
Engineering an Atherosclerosis-Resistant Endothelium
-
批准号:7672486
-
项目类别:
-
资助金额:$72.74万
-
财政年份:2007
-
负责人:Martin A Schwartz
-
依托单位:
Engineering an Atherosclerosis-Resistant Endothelium
-
批准号:7463907
-
项目类别:
-
资助金额:$69.82万
-
财政年份:2007
-
负责人:Martin A Schwartz
-
依托单位:
Engineering an Atherosclerosis-Resistant Endothelium
-
批准号:7904865
-
项目类别:
-
资助金额:$71.24万
-
财政年份:2007
-
负责人:Martin A Schwartz
-
依托单位:
Engineering an Atherosclerosis-Resistant Endothelium
-
批准号:7290489
-
项目类别:
-
资助金额:$70.24万
-
财政年份:2007
-
负责人:Martin A Schwartz
-
依托单位:
Biosensor
-
批准号:7195625
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2006
-
负责人:Martin A Schwartz
-
依托单位:
Integrins in the Endothelial Response to Fluid Shear Stress
-
批准号:8254438
-
项目类别:
-
资助金额:$39.21万
-
财政年份:2003
-
负责人:Martin A Schwartz
-
依托单位: